(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 17.48% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.92%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.72%.
Natera's revenue in 2026 is $2,500,925,000.On average, 25 Wall Street analysts forecast NTRA's revenue for 2026 to be $408,450,269,464, with the lowest NTRA revenue forecast at $388,256,900,602, and the highest NTRA revenue forecast at $423,201,453,810. On average, 25 Wall Street analysts forecast NTRA's revenue for 2027 to be $485,643,360,362, with the lowest NTRA revenue forecast at $437,666,207,392, and the highest NTRA revenue forecast at $524,884,375,030.
In 2028, NTRA is forecast to generate $585,034,835,470 in revenue, with the lowest revenue forecast at $534,479,805,624 and the highest revenue forecast at $658,790,757,200.